Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2025-12-25 @ 12:24 AM
NCT ID:
NCT06620458
Eligibility Criteria:
Inclusion Criteria:
* Age:
18 years and older.
* Diagnosis:
Diagnosed with coronary artery disease with native large vessel lesions confirmed by coronary angiography.
* Treatment Plan:
Scheduled to receive paclitaxel drug-coated balloon angioplasty.
* Informed Consent:
Patients have been fully informed about the nature and purpose of the study, and have voluntarily agreed to participate, with signed informed consent.
* Physiological Status:
Cardiac function classified as NYHA I-III.
Exclusion Criteria:
* Allergy History:
Known allergies to paclitaxel or any materials used in angioplasty (e.g., contrast agents).
* Severe Complications:
Uncontrolled hypertension (systolic blood pressure \>180 mmHg or diastolic blood pressure \>110 mmHg).
* Other Medical Conditions:
Active bleeding or clotting disorders.
* Other serious diseases with a life expectancy of less than 1 year (e.g., advanced cancer).
* Pregnancy or Nursing: Women who are currently pregnant or breastfeeding.
* Participation in Other Studies: Currently participating in other clinical trials that might affect the results of this study.
* Psychological or Behavioral Factors: History of psychiatric or behavioral disorders that could interfere with adherence to study protocols, or communication barriers that prevent understanding of study requirements.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06620458
Study Brief:
Protocol Section:
NCT06620458